The role of procalcitonin (PCT) in advanced urological cancer patients with high grade fever

The role of procalcitonin (PCT) in advanced urological cancer patients with high grade fever - PCT in advanced urological cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011591

Enrollment

100

Registered

2013-08-28

Start date

2013-08-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced urological cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: metastatic, locally invasive, or large (longest diameter >5cm, or total of longest diameter >5cm in multiple lesions) urological cancer including urothelial cancer, renal cell cancer, germ cell cancer, prostate cancer, penile cancer, and cancer or sarcoma arisen in genitourinary systems)

Exclusion criteria

Exclusion criteria: patients who did not agree with this study

Design outcomes

Secondary

Measure	Time frame
the relation between the rate of bacterial infection and other factors such as primary tumor, age, white blood cell count, CRP, body temparature	—

Primary

Measure	Time frame
comparison of the rate of bacterial infection between defferent PCT levels	—

Countries

Japan

Contacts

Public ContactKouji Izumi

Kanazawa University Graduate School of Medical Science Department of Integrative Cancer Therapy and Urology

azuizu2003@yahoo.co.jp076-265-2393

Outcome results